Member Info for DeBull

No chance, they are spamming .

If someone had bought £20k, we would not be negative.

CO funded by NIHR & Prostate Cancer UK to.

Https://www.icr.ac.uk/news-archive/new-screening-trial-to-save-thousands-of-men-s-lives-from-prostate-cancer#:~:text=TRANSFORM%20will%20test%20new%20approaches,and%20many%20thousands%20more%20worldwide.

PYC have links to ICR and Royal Marsden to.

Old 1!!

I was looking at old RNS's an that 1 was at the top, forgot to refresh......doh

Https://www.londonstockexchange.com/news-article/PYC/contract-award/15710389

Ant15, s usual you are correct. PYC have worked with Merck & co in 2014.

https://www.physiomics.co.uk/disclosure-of-large-pharma-partner-merck-co/

Laura, sorry for doubting your acumen.

Laura.

That is great. However, this is not the "Merck" client that uses PYC.

The "Merck" that uses PYC is Merck KGaA (Merck group)

The "Merck" in the news feed is Merck & co.

Laura, are you saying that all the 1.48 trades during the day were buys?

Am i allowed to say that one of VAL's new NED's looks a interesting person, especially the link that Martin Gouldstone was CBO at BenevolentAI.

Thanks for your input.

Can i ask with your background, why in your opinion have the new CEO not bought any shares yet?

Steady buying all day, and as someone else suggested, this happened last Friday, but only difference is last Friday sellers arrived at the end & carried on during the week.

Hopefully this a turnaround?

Trench, did they not start off in Oz and have a office there to?

You would have thought so Laura?

However, the lowly SP and near lack of interest in people buying these shares, along with only a trickle of deals, shows that either there is fierce competition within this particular market, or what PYC are offering is not (yet) needed by drug development companies or these companies are getting the data they need from other sources or in house?

PYC have said they are in the "sweet spot", yet this sweet spot has not amounted to much yet? Maybe the FDA's #ProjectOptimus can be the saviour?

I believe it was completed sometime ago,

https://www.physiomics.co.uk/wp-content/uploads/2019/04/2017-1-11-Company-Update-2.pdf

We are talking 2015-16 timelines here?

The candidate was CCT245737, which was renamed PNT737, then licensed out to Sierra by which time it was SRA737 https://www.edisongroup.com/research/sierra-oncology-returns-rights-to-sra737/31442/ Sierra bought out by GSK and then SRA737 rights were returned to SAR after GSK's purchase of Sierra. Or something along those lines!

What it does show is that PYC have been on this "Personal medicine" train for nearly a decade.

Thank you Ant fr that great post.

So, PYC did not reply, not even to say thanks but not thanks? That is poor to be honest?

I have reached out to them, but apart from a cordial reply, nothing about the subject in hand.

I can only go on the reply JM gave to a IM some months ago about why BOD dont see buying stock as the best way to grow the business?

Be interesting to hear Ant15's take on this?

Meanwhile, are we heading sub 1p?

Ant, nice paragraph there.

Have you migrated here from elsewhere?

Am i right in thinking you may have some historical ties with the stock?

The drop yesterday was i think in part after a few days of selling. I did not see any B&I swaps going through, normally you can match largish trades, discounting a few shares per trade with a B&I.

We then had over 15 buys ranging from a few hundred to over 1 thousand £'s all very much needed, However, seeing trades of 250k+ is what is required.

AACR Annual meeting is in San Diego 5th to 10th April, i wonder if PYC will attend, or submit abstract?

Are you referring to the 600k trade? How do we know it was a buy?

Could it be Peter has dipped his hands in his pockets?

Looking back through search engine, they partnered in 2004 / 2005

https://www.physiomics.co.uk/physiomics-and-bayer-launch-a-new-service/

Https://www.bayer.com/en/us/news-stories/fda-breakthrough-therapy-designation#:~:text=Berlin%2C%20Germany%2C%20February%2026%2C,tumors%20have%20activating%20HER2%20(ERBB2)

https://twitter.com/Bayer/status/1762054925838606679

Yesterday, Physiomics reposted ( retweeted) a post from Bayer. The Bayer post was sent out om X on the 26th Feb 2024.

In the post, about pipeline and FDA granting Tyrosine Kinase inhibitor for non small cell lung cancer.

I have not followed Physiomics for as long as some here. Have PYC worked with Bayer in the past? Was it anything to do with the TK inhibitor? Just found it intriguing that out of nowhere, PYC repost Bayer, which i also think is a first?